Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
University of Texas Health Science Center at Houston, TX, USA. Maureen.D.Mayes@uth.tmc.edu
Maureen D
MD
Mayes
D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D017675:CREST Syndrome / Q000150:complications / Q000378:metabolism; D003240:Connective Tissue Diseases / Q000150:complications / Q000378:metabolism*; D018849:Controlled Clinical Trials as Topic; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D017466:Receptors, Endothelin / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D013449:Sulfonamides / Q000627:therapeutic use
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D017466:Receptors, Endothelin; D013449:Sulfonamides; D000077300:Bosentan